Brentuximab vedotin in patients who are ineligible for autologous stem cell transplant with relapsed or refractory Hodgkin lymphoma: a United Kingdom and Germany retrospective study.
Brockelmann, P Zagadailov, E Corman, S Hagan, M Chirikov, V Johnson, C Macahilig, C Seal, B Dalal, M
Brockelmann, P
Zagadailov, E
Corman, S
Hagan, M
Chirikov, V
Johnson, C
Macahilig, C
Seal, B
Dalal, M
Citations
Altmetric:
Abstract
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Brentuximab vedotin in patients who are ineligible for autologous stem cell transplant with relapsed or refractory Hodgkin lymphoma: a United Kingdom and Germany retrospective study. 2016, 101(S5):50-51 Haematologica